Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic value of the hDMP1-ARF-Hdm2-p53 pathway in breast cancer

Published:2012-10-08 Issue:35 Volume:32 Page:4120-4129
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Maglic D,Zhu S,Fry E A,Taneja P,Kai F,Kendig R D,Sugiyama T,Miller L D,Willingham M C,Inoue K

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2012423.pdf

Reference37 articles.

1. Hortbagyi GN . Treatment of breast cancer. N Engl J Med 1998; 339: 974–984 Review.

2. Ross JS, Hortobagyi GN (eds). Molecular Oncology of Breast Cancer. Jones and Bartlett Publishers, Sudbury, Massachusetts, 2005.

3. Siegel R, Ward E, Brawley O, Jemal A . Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212–236.

4. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 2006; 10: 529–541.

5. Smeets SJ, Harjes U, van Wieringen WN, Sie D, Brakenhoff RH, Meijer GA et al. To DNA or not to DNA/ That is the Question, When It Comes to Molecular Subtyping for the Clinic!. Clin Cancer Res 2011; 17: 4959–4964.

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improved cognitive impairments by silencing DMP1 via enhancing the proliferation of neural progenitor cell in Alzheimer‐like mice;Aging Cell;2022-04-02

2. CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal;The EMBO Journal;2022-01-17

3. SRSF5 regulates alternative splicing of DMTF1 pre-mRNA through modulating SF1 binding;RNA Biology;2021-07-22

4. Survival of Lung Cancer Patients Dependent on the LOH Status for DMP1, ARF, and p53;International Journal of Molecular Sciences;2020-10-27

5. c-MYB and DMTF1 in Cancer;Cancer Investigation;2019-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3